For instance, IFN-γ signaling is known as an essential effector molecule for anti-tumor immune response, which must bind the IFN-γ receptor (IFNGR1 or IFNGR2) to modulate the JAK–STAT pathways and affects the immune cell activation (Dunn et al., 2005). This evidence concerns the gene IFNGR2 and neoplasm.